Hudson Bay Capital Management LP Rigel Pharmaceuticals Inc Transaction History

Hudson Bay Capital Management LP

$21.9 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.1 - $12.2 $770,000 - $8.54 Million	-700,000 Reduced 17.5%	3,300,000 $3.89 Million
Q2 2022 Aug 12, 2022	BUY	$0.67 - $3.19 $134,000 - $638,000	200,000 Added 5.26%	4,000,000 $4.52 Million
Q1 2022 May 16, 2022	SELL	$2.22 - $3.45 $444,000 - $690,000	-200,000 Reduced 5.0%	3,800,000 $11.4 Million
Q4 2021 Feb 14, 2022	BUY	$2.36 - $3.57 $2.81 Million - $4.25 Million	1,190,000 Added 42.35%	4,000,000 $10.6 Million
Q3 2021 Nov 15, 2021	BUY	$3.5 - $4.5 $1.09 Million - $1.4 Million	310,000 Added 12.4%	2,810,000 $10.2 Million
Q2 2021 Aug 16, 2021	SELL	$3.09 - $4.54 $138,741 - $203,846	-44,900 Reduced 1.76%	2,500,000 $10.9 Million
Q1 2021 May 14, 2021	SELL	$3.35 - $4.93 $971,835 - $1.43 Million	-290,100 Reduced 10.23%	2,544,900 $8.7 Million
Q4 2020 Feb 12, 2021	SELL	$2.35 - $3.74 $822,500 - $1.31 Million	-350,000 Reduced 10.99%	2,835,000 $9.92 Million
Q3 2020 Nov 12, 2020	SELL	$1.78 - $4.13 $238,251 - $552,796	-133,849 Reduced 4.03%	3,185,000 $7.64 Million
Q2 2020 Aug 12, 2020	SELL	$1.41 - $2.05 $255,422 - $371,359	-181,151 Reduced 5.18%	3,318,849 $6.07 Million
Q1 2020 May 14, 2020	BUY	$1.27 - $3.0 $635,000 - $1.5 Million	500,000 Added 16.67%	3,500,000 $5.46 Million
Q4 2019 Feb 12, 2020	BUY	$1.6 - $2.43 $400,000 - $607,500	250,000 Added 9.09%	3,000,000 $6.42 Million
Q3 2019 Nov 13, 2019	BUY	$1.63 - $2.62 $847,600 - $1.36 Million	520,000 Added 23.32%	2,750,000 $5.14 Million
Q2 2019 Aug 14, 2019	BUY	$2.02 - $2.61 $202,000 - $261,000	100,000 Added 4.69%	2,230,000 $5.82 Million
Q1 2019 May 15, 2019	BUY	$2.0 - $2.65 $60,000 - $79,500	30,000 Added 1.43%	2,130,000 $5.47 Million
Q4 2018 Feb 13, 2019	BUY	$2.08 - $3.36 $301,600 - $487,200	145,000 Added 7.42%	2,100,000 $4.83 Million
Q3 2018 Nov 14, 2018	SELL	$2.6 - $3.59 $117,000 - $161,550	-45,000 Reduced 2.25%	1,955,000 $6.28 Million
Q2 2018 Aug 13, 2018	BUY	$2.83 - $4.11 $2.12 Million - $3.08 Million	750,000 Added 60.0%	2,000,000 $5.66 Million
Q3 2017 Nov 13, 2017	BUY	$2.18 - $2.57 $2.73 Million - $3.21 Million	1,250,000	1,250,000 $3.18 Million

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Account